

[2]
Liu T, Wang S, Liu H, et al. Detection of vertebral metastases: a meta-analysis comparing MRI, CT, PET, BS and BS with SPECT. J Cancer Res Clin Oncol 2017;143:457–65.
[3]
Ringham BM, Alonzo TA, Grunwald GK, Glueck DH. Estimates of sensitivity and specificity can be biased when reporting the results of the second test in a screening trial conducted in series. BMC Med Res Methodol 2010;10:3.[4]
Hamoen EH, de Rooij M, Witjes JA, Barentsz JO, Rovers MM. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for prostate cancer detection with multiparametric magnetic reso- nance imaging: a diagnostic meta-analysis. Eur Urol 2015;67: 1112–21.
[5]
Shen G, Deng H, Hu S, Jia Z. Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis. Skeletal Radiol 2014;43:1503–13.Jae Heon Kim
a,b,
*
Bora Lee
c
Benjamin I. Chung
a
a
Departmentof Urology,StanfordUniversityMedical Center, Stanford,CA, USA
b
Department of Urology, Soonchunhyang University Hospital,
Soonchuhyang University Medical College, Seoul, Korea
c
Department of Biostatistics, Clinical Trial Center, Soonchunhyang
University Bucheon Hospital, Bucheon, Korea
*Corresponding author. Department of Urology, Soonchunhyang
University Seoul Hospital, 59 Daesagwan-ro, Yongsan-gu,
Seoul 140-743, South Korea. Tel. +82 2 7099378; Fax: +82 2 7105190.
E-mail address:
piacekjh@hanmail.net(J.H. Kim).
June 16, 2017
E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) e 1 6 4 – e 1 6 5
e165